TELADOC HEALTH INC

Insider Trading & Executive Data

TDOC
NYSE
Healthcare
Health Information Services

Start Free Trial

Get the full insider signal for TDOC

167 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
167
1 in last 30 days
Buy / Sell (1Y)
72/95
Acquisitions / Dispositions
Unique Insiders (1Y)
16
Active in past year
Insider Positions
65
Current holdings
Position Status
62/3
Active / Exited
Institutional Holders
349
Latest quarter
Board Members
55

Compensation & Governance

Avg Total Compensation
$5.8M
Latest year: 2024
Executives Covered
13
Comp records available
Form 8-K Events (1Y)
5
Personnel Changes (1Y)
3
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
1
Board Appointments (1Y)
0
Board Departures (1Y)
3

Restricted Sales

Form 144 Filings (1Y)
32
Form 144 Insiders (1Y)
6
Planned Sale Shares (1Y)
207.7K
Planned Sale Value (1Y)
$1.6M
Price
$5.24
Market Cap
$933.5M
Volume
59,214.49
EPS
$-1.14
Revenue
$2.5B
Employees
5.5K
About TELADOC HEALTH INC

Company Overview

Teladoc Health (TDOC) is a global virtual-care provider operating two reportable segments: Integrated Care (B2B contracts with employers, health plans, hospitals) and BetterHelp (D2C mental‑health subscription platform). The business is largely recurring—about 86% of 2024 revenue came from access fees—and scale is driven by membership (≈94 million U.S. members reported in 2024), visit volume (~17.3 million telehealth visits in 2024), and cross‑sell of chronic‑care, primary care and mental‑health offerings. Teladoc emphasizes a technology‑and‑data‑driven operating model (cloud/EMR integration, AI engagement, remote monitoring devices) and faces seasonality, provider/licensure dependencies, meaningful regulatory complexity (HIPAA, state licensure, Stark/Anti‑Kickback, data‑privacy regimes), and competitive pressure in both enterprise and direct‑to‑consumer channels.

Executive Compensation Practices

Given Teladoc’s subscription‑based model and focus on membership, utilization and recurring access fees, executive pay is likely tied to a mix of near‑term financial KPIs (revenue growth, adjusted EBITDA, free cash flow) and operating/engagement metrics (membership growth, PMPM/ARPU, paying users for BetterHelp, chronic‑care enrollments and visit volumes). The company’s recent Goodwill impairments (BetterHelp 2024: $790M; additional Catapult impairment in 2025) and variable GAAP results make non‑GAAP measures (Adj. EBITDA, cash generation) important for annual bonuses and performance‑based equity, while long‑term equity (PSUs/RSUs, time‑based awards) is likely used for retention—especially around acquisitions and key product/regulatory milestones (device clearances, platform integrations). Cash conservation needs (convertible note maturities and periodic acquisition activity) suggest a heavier reliance on equity and performance vesting instead of large cash payouts, and you should expect clawbacks, double‑trigger protections and change‑in‑control or retention awards tied to integration outcomes.

Insider Trading Considerations

Insiders will have access to highly material operational metrics (member counts, paying‑user trends at BetterHelp, contract renewals, visit volumes, refund exposures) and regulatory outcomes, so trading patterns often cluster around earnings, membership updates, acquisition announcements, device or data‑privacy rulings, and financing events (notably the convertible note maturities and any equity raises). Because equity is likely a large portion of pay, executives may use scheduled 10b5‑1 plans to diversify; however, look for atypical Form 4 activity around quarter ends, impairment disclosures, or large client wins/losses as higher‑information events. Finally, the healthcare/regulatory environment (HIPAA, state licensure, anti‑kickback/FCPA exposure) increases the chance of sharp information‑driven moves, so short‑term spikes in insider buying or selling around regulatory or legal developments can be informative for traders and researchers.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for TELADOC HEALTH INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime